Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Intervalo de ano de publicação
3.
Med. cután. ibero-lat.-am ; 37(5): 230-232, sept.-oct. 2009. ilus
Artigo em Espanhol | IBECS | ID: ibc-80184

RESUMO

El imatinib es una inhibidor del enzima tirosin-quinasa. Se emplea en el tratamiento de la leucemia mieloide crónica, del dermatofibrosarcoma protuberansy de tumores gastrointestinales. Las reacciones cutáneas relacionadas con imatinib son frecuentes y suceden en un 9’5%-69% de los pacientes,según las series. Las más frecuentes son exantemas maculopapulosos, edemas generalizados y edema periorbitario. Hasta el momento se han descritopocos pacientes con erupciones liquenoides por imatinib. Presentamos un nuevo caso de erupción liquenoide por imatinib (AU)


Imatinib mesylate is a tyrosine kinase inhibitor. It is used to treat chronic myeloid leukaemia, dermatofibrosarcoma protuberans and gastrointestinalstromal tumours. Cutaneous reactions to imatinib are frequent and occur in 9’5-69% of patients, depending on the series reported. Maculopapulareruptions, generalized edema and periorbital edema are the most common adverse events observed. Lichenoid eruptions are very rare. We report anew case of imatinib-induced oral lichenoid eruption (AU)


Assuntos
Humanos , Masculino , Idoso , Mucosa Bucal/patologia , Líquen Plano Bucal/induzido quimicamente , Tirosina/antagonistas & inibidores , Antineoplásicos/efeitos adversos , Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico
5.
Actas Dermosifiliogr ; 98(1): 42-4, 2007.
Artigo em Espanhol | MEDLINE | ID: mdl-17374332

RESUMO

Leishmania braziliensis is the main etiologic agent of leishmaniasis in South America. A 9-year-old boy consulted for the presence of round, ulcerative lesions with raised borders that were painful and have appeared after a travel to Bolivia and Brazil. The culture for parasites showed leishmanias and the PCR was positive for L. braziliensis. The patient underwent treatment with itraconazol but due to the persistence of lesions he received liposomal amphotericin B with complete resolution of the lesions. In all lesions by L. braziliensis the treatment must be systemic due to the risk of mucosal dissemination. Liposomal amphotericin B is a convenient alternative to pentavalent antimonials given its efficacy and good tolerance.


Assuntos
Anfotericina B/administração & dosagem , Antiprotozoários/administração & dosagem , Leishmania braziliensis , Leishmaniose Cutânea/tratamento farmacológico , Animais , Criança , Humanos , Lipossomos , Masculino , Viagem
6.
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. impr.) ; 33(2): 100-101, feb. 2007. ilus
Artigo em Es | IBECS | ID: ibc-63703

RESUMO

La larva migrans cutánea es un proceso secundario a la penetración en la piel de una larva de nematodo que se desplaza por la epidermis. Es típico de zonas tropicales. Su presentación clínica se caracteriza por unos trayectos lineales tortuosos, habitualmente pruriginosos, que se localizan con mayor frecuencia en los pies, aunque pueden aparecer en otras localizaciones. Aunque es un proceso autolimitado suele requerir tratamiento por el intenso prurito que produce y las posibles complicaciones asociadas, principalmente la sobreinfección bacteriana. Presentamos un caso de un paciente con varias lesiones de larva migrans cutánea después de realizar un viaje a Brasil


Cutaneous larva migrans is an eruption caused by a nematode larva that penetrates the skin and moves through the epidermis. It is typical of tropical areas. Its clinical presentation is characterized by linear pruritic lesions that are usually serpiginous. This is most often located on the feet, although it may appear in other locations. Although it is a self-limited condition, it generally requires treatment due to the intense itching it produces and the possible associated complications, mainly secondary bacterial infection. We present a case of a male patient with several cutaneous larva migrans lesions after having traveled to Brazil


Assuntos
Humanos , Masculino , Adulto , Larva Migrans/diagnóstico , Larva Migrans/tratamento farmacológico , Ancylostoma/patogenicidade , Prurido/tratamento farmacológico
7.
Actas dermo-sifiliogr. (Ed. impr.) ; 98(1): 42-44, ene. 2007. ilus
Artigo em Es | IBECS | ID: ibc-052373

RESUMO

Leishmania braziliensis es el principal agente etiológico de leishmaniasis cutánea en América del Sur. Un varón de 9 años consultó por lesiones redondeadas ulceradas de bordes sobreelevados, que eran dolorosas y habían aparecido después de un viaje por Bolivia y Brasil. En el cultivo de parásitos se objetivaron Leishmanias y la reacción en cadena de la polimerasa (PCR) para L. braziliensis fue positiva. El paciente realizó tratamiento con itraconazol, y por persistencia de las lesiones inició anfotericina B liposomal con resolución completa de las mismas. En toda lesión por L. braziliensis el tratamiento debe ser sistémico por el riesgo de diseminación mucosa. La anfotericina B liposomal es una buena alternativa a los antimoniales pentavalentes por su eficacia y buena tolerancia


Leishmania braziliensis is the main etiologic agent of leishmaniasis in South America. A 9-year-old boy consulted for the presence of round, ulcerative lesions with raised borders that were painful and have appeared after a travel to Bolivia and Brazil. The culture for parasites showed leishmanias and the PCR was positive for L. braziliensis. The patient underwent treatment with itraconazol but due to the persistence of lesions he received liposomal amphotericin B with complete resolution of the lesions. In all lesions by L. braziliensis the treatment must be systemic due to the risk of mucosal dissemination. Liposomal amphotericin B is a convenient alternative to pentavalent antimonials given its efficacy and good tolerance


Assuntos
Masculino , Criança , Humanos , Leishmania braziliensis/isolamento & purificação , Leishmania braziliensis/patogenicidade , Anfotericina B/uso terapêutico , Leishmaniose Cutânea/diagnóstico , Leishmaniose Cutânea/etiologia , Itraconazol/uso terapêutico , Leishmaniose Cutânea/patologia , Leishmaniose Cutânea/terapia
10.
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. impr.) ; 32(6): 304-306, jun. 2006. ilus
Artigo em Es | IBECS | ID: ibc-047894

RESUMO

Tinea corporis es producida por la infección por dermatofitos de la piel lampiña. Habitualmente son lesiones poco extensas en pacientes inmunocompetentes. Un varón de 40 años, de origen rumano, consultó por lesiones cutáneas pruriginosas anulares de hasta 30 cm, de borde papuloso eritemato escamoso, afectando hasta un 60% de la superficie corporal total. Se realizó una visión con hidróxido de potasio (KOH) y cultivo de las lesiones, que resultaron positivos para Trichophyton rubrum, estableciéndose el diagnóstico de tinea corporis. Las condiciones sociosanitarias desempeñan un papel de gran importancia en las infecciones por dermatofitos, siendo un grupo de riesgo la población inmigrante. En el caso presentado, pensamos que es la situación sociosanitaria del paciente la que ha debido determinar la presentación clínica peculiar de una tinea corporis de tan gran extensión


Tinea corporis is caused by infection of glabrous skin from dermatophytes. They are generally fairly localized lesions in immunocompetent patients. A 40 year old male, of Romanian origin, consulted about itchy cutaneous lesions with the shape of large rings up to 30 cm in diameter, with a scaly erythematous border containing papules. It affected up to 60% of the total body surface. A KOH test and culture of the lesions were done, and were positive for trichophyton rubrum, the diagnosis of tinea corporis being established. Socio-health care conditions play a very important role in infections due to dermatophytes, the immigrant population being a risk group. In the case presented, we think that the socio-health care situation of the patient is that which must determine the distinctive clinical presentation of such a widespread tinea corporis


Assuntos
Masculino , Adulto , Humanos , Antifúngicos/uso terapêutico , Itraconazol/uso terapêutico , Tinha dos Pés/tratamento farmacológico , Tinha dos Pés/diagnóstico , Trichophyton/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...